Ultralife

Ultralife Corp. engages in the manufacture and sale of products for power solutions. It operates through the Battery & Energy Products and Communications System segments. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, thin cell and various other non-rechargeable batteries, in addition to rechargeable batteries, uninterruptable power supplies, charging systems, and accessories such as cables. The Communications System segment comprises radio frequency amplifiers, power supplies, cable and connector assemblies, amplified speakers, equipment mounts, case equipment, integrated communication systems for fixed or vehicle applications, and communications and electronics systems design. The company was founded by Arthur M. Liberman in December 1990 and is headquartered in Newark, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Ultralife reports record sales in Q4 2022 amidst challenges

Ultralife Corporation delivered robust financial results in Q4 2022, showcasing growth in sales, segments, and profitability, despite facing challenges like supply chain disruptions and cybersecurity incidents.
The company's strategic strengths in market focus, operational resilience, and debt reduction plans position it well to capitalize on opportunities for further growth and innovation in the future.
Analysts' inquiries highlighted areas for improvement and risk mitigation, signaling a proactive approach by Ultralife to address challenges and drive sustainable value creation.

Ultralife reports revenue growth amidst cyber attack challenges in Q1

Ultralife resilient in Q1 2023 with revenue growth despite cyber attack impact.
Strong government defense sales offset commercial sales decline.
Company focused on executing backlog, improving margins, and driving growth.
Challenges include cyber incident impact, net loss, and supply chain issues.

Ultralife reports stellar Q2 results, eyes margin improvement and growth

Ultralife Corporation delivered exceptional Q2 2023 results, marked by substantial revenue growth, profitability, and a record backlog, showcasing strong market demand.
The company's focus on improving gross margins, efficient cost management, and growth initiatives in key segments positions it well for future success and market leadership.
While challenges like maintaining margins and executing backlog exist, Ultralife's solid financial performance, operational stability, and growth opportunities paint a positive outlook.
By leveraging opportunities for margin enhancement, market expansion, and innovation, Ultralife can navigate challenges and capitalize on its strengths for sustained growth and profitability.

Ultralife reports robust Q3 performance, eyes growth through strategic initiatives

Ultralife's Q3 2023 performance reflects strong financial health, with notable improvements in gross margin, operating profit, and revenue growth.
The company's strategic focus on debt reduction, profitability enhancement, and organic growth initiatives underscores a promising outlook for future success.
Challenges lie in consistently improving gross margins, maintaining backlog levels, and effectively balancing debt repayment with growth investments.

Ultralife (ULBI) posts strong Q4 results, eyes growth opportunities

Ultralife (ULBI) delivered robust financial performance in Q4 and full-year 2023, driven by strong sales growth and margin improvement.
The company faces challenges in production capacity, operational efficiency, and project launches, requiring ongoing attention.
Strategic focus on gross margin enhancement, organic growth, and new product opportunities present avenues for future expansion.
With a solid financial position, Ultralife is well-positioned to capitalize on market opportunities and navigate potential challenges.

Ultralife reports robust Q1 earnings, poised for strategic growth

Ultralife Corporation's Q1 2024 performance reflects strong revenue growth, margin improvement, and profitability milestones.
The company's focus on key segments like Battery & Energy Products and Communication Systems drove significant revenue increases.
While challenges like sustaining margins and managing expenses exist, Ultralife is well-positioned to capitalize on growth opportunities.
Investors should take note of Ultralife's turnaround in earnings and strategic positioning for future growth.

Ultralife posts robust Q2 results, eyes M&A opportunities amid challenges

Ultralife's Q2 performance showcased strong sales, debt reduction, and margin improvement.
While facing challenges in the Communications Systems segment, the company's strategic focus on debt management and market diversification presents growth opportunities.
Investors should take note of Ultralife's solid financial position and potential for future expansion through M&A.

Ultralife reports mixed Q3 results, eyes growth through Electrochem acquisition

Ultralife's Q3 performance reflects mixed results with revenue growth in Battery & Energy Products but decline in Communication Systems.
The company faces challenges in revenue diversification, margin pressure, and increased operating expenses.
However, strategic initiatives and the Electrochem acquisition offer growth opportunities in high-reliability markets.
Overall, Ultralife's focus on efficiency and profitability amidst challenges positions it for long-term success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Ultralife Corporation (NASDAQ:ULBI ) Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ET Company Participants Jody Burfening - Investor Relations Mike Manna - President and Chief Executive Officer Phil Fain - Chief Financial Officer Conference Call Participants Josh Sullivan - The Benchmark Company John Deysher - Pinnacle Operator Good day, and thank you for standing by. Welcome to the Ultralife Corporation Third Quarter 2024 Results Conference Call.

Ultralife Corporation (ULBI) Q3 2024 Earnings Call Transcript

NEWARK, N.Y., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the third quarter ended September 30, 2024 as follows:

Ultralife Corporation Reports Third Quarter Results

NEWARK, N.Y., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) completed its acquisition of all outstanding shares of Electrochem Solutions, Inc. (“Electrochem”) for $50.0 million in cash from Integer Holdings Corporation (NYSE: ITGR) on October 31, 2024.

Ultralife Corporation Completes Acquisition of Electrochem Solutions, Inc.

Strong revenue growth since Q1 2022, driven by strong demand for battery and energy products in commercial and defense markets. Institutional investors increased positions in the last quarter, and the valuation ratios are near five-year lows. The company improved its balance sheet by reducing debt and maintaining strong liquidity ratios.

Ultralife Corporation: A Battery Stock Charging Up For A Comeback

Shares of Ultralife Corp (ULBI, Financial) surged 8.55% in mid-day trading on Oct 2. The stock reached an intraday high of $10.05, before settling at $10.03, up from its previous close of $9.24.

Ultralife Corp (ULBI) Trading 8.55% Higher on Oct 2

ULBI's share price fell to $7 following a cyber-attack, but has since recovered to $11.50, making a 50% return in 6 months. ULBI's growth in sales revenue is driven by its battery and energy products segment, with a focus on lithium-ion batteries and communication systems. The company's adoption of lean manufacturing techniques, margin improvement, and debt paydown have led to a significant increase in performance and future cash generation, warranting a Strong Buy recommendation with a price target of $35.

Ultralife: I Bought The Dip; Here Comes The Growth

Ultralife Corporation (NASDAQ:ULBI ) Q2 2024 Results Conference Call July 25, 2024 8:30 AM ET Company Participants Jody Burfening - IR Mike Manna - President and CEO Phil Fain - CFO Conference Call Participants Josh Sullivan - The Benchmark Company Operator Good day, and thank you for standing by. Welcome to Ultralife Corporation Second Quarter 2024 Results Conference Call.

Ultralife Corporation (ULBI) Q2 2024 Earnings Call Transcript

NEWARK, N.Y., July 25, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2024 with the following highlights:

Ultralife Corporation Reports Second Quarter Results

NEWARK, N.Y., July 11, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2024 before the market opens on Thursday, July 25, 2024.

Ultralife Corporation to Report Second Quarter Results on July 25, 2024

Ultralife Corporation specializes in batteries for government, military, and private sectors, with a focus on communications systems. Recent growth initiatives include new product developments like EL8000 Case Systems and Thin Cell Batteries. The company has shown strong revenue growth, successful M&A track record, gross margin expansion, and stable operating expenses, making it a promising investment.

Ultralife Corporation Is Attractive Here

RADCOM

Penny stocks are risky yet highly lucrative if selected correctly. Moreover, penny stocks are often idiosyncratically driven, meaning they possess diversification potential.

3 Penny Stocks Poised to Create a Boatload of New Millionaires

Ultralife Corporation (NASDAQ:ULBI ) Q1 2024 Earnings Call Transcript April 25, 2024 8:30 AM ET Company Participants Jody Burfening - IR Mike Manna - President and CEO Phil Fain - CFO Conference Call Participants Josh Sullivan - The Benchmark Company Samuel McColgan - Breakout Investors Operator Good day, and thank you for standing by. Welcome to the Ultralife Corporation First Quarter Conference Call.

Ultralife Corporation (ULBI) Q1 2024 Earnings Call Transcript

NEWARK, N.Y., April 25, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the first quarter ended March 31, 2024 with the following highlights:

Ultralife Corporation Reports First Quarter Results

ULBI is likely to deliver above-market returns in the next two years, with improving fundamentals and a modest valuation. They should benefit from growth in the battery market and increased military spending. Management is delivering on growth and margin improvement; EPS could double in 2024.

Ultralife Corporation: Ready To Surge

NEWARK, N.Y., April 11, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its first quarter results for the period ended March 31, 2024 before the market opens on Thursday, April 25, 2024.

Ultralife Corporation to Report First Quarter Results on April 25, 2024

Ultralife Corporation (ULBI) Q4 2023 Earnings Call Transcript

NEWARK, N.Y., Feb. 15, 2024 (GLOBE NEWSWIRE) --  Ultralife Corporation (NASDAQ:   ULBI) reported operating results for the fourth quarter and full year ended December 31, 2023.

Ultralife Corporation Reports Fourth Quarter Results

NEWARK, N.Y., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for the period ended December 31, 2023 before the market opens on Thursday, February 15, 2024.

Ultralife Corporation to Report Fourth Quarter Results on February 15, 2024

Ultralife Corporation shares have experienced a pullback of over 30%, making it an attractive investment opportunity. ULBI focuses on margin improvement and growing sales, with plans to pay down debt and evaluate further takeover targets. The company's range of new products and innovations is expected to drive revenue to new highs in FY2023 and beyond.

Ultralife: Buy The Dip

Ultralife Corporation (NASDAQ:ULBI ) Q3 2023 Earnings Conference Call October 26, 2023 8:30 AM ET Company Participants Jody Burfening - Investor Relations Michael Manna - President & Chief Executive Officer Philip Fain - Chief Financial Officer Conference Call Participants Josh Sullivan - Benchmark Company Operator Good day, and thank you for standing by. Welcome to the Ultralife Corporation Third Quarter 2020 Results Conference Call.

Ultralife Corporation (ULBI) Q3 2023 Earnings Call Transcript

NEWARK, N.Y., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its third quarter results for the period ended September 30, 2023 before the market opens on Thursday, October 26, 2023.

Ultralife Corporation to Report Third Quarter Results on October 26, 2023

Ultralife's strong revenue and earnings growth can drive the stock to above-average gains. The valuation is reasonable, leaving room for upside for the stock. Ultralife is poised to benefit over multiple years from the expected industry growth for lithium-ion batteries.

Ultralife: Stock To Outperform With Growth From Multiple Industries

Ultralife manufactures portable power solutions and communication systems for a range of industries. The company has put in place certain initiatives that could lead to gross margin progression this year and next. Investors are advised to wait for a pullback in the price action, considering the current risk-reward on the charts.

Ultralife Corporation: On The Up, But Wait For A Better Entry Point

Ultralife Corporation reports an impressive increase in backlog, indicating potential for future net sales growth. Communications Systems segment shows significant revenue growth, driven by demand from government, defense, and medical customers. Market analysts have positive expectations for Ultralife, with projected growth in net sales, EBITDA, and net income.

Ultralife: Backlog Increase And FCF Growth Imply Undervaluation

Ultralife Corporation (NASDAQ:ULBI ) Q2 2023 Earnings Conference Call July 27, 2023 8:30 AM ET Company Participants Jody Burfening - IR Michael Manna - President and CEO Philip Fain - CFO Conference Call Participants Joshua Sullivan - The Benchmark Company Operator Good day and thank you for standing by. Welcome to the Ultralife Earnings Conference Call.

News for Ultralife Stock (ULBI)